Polymarket’s expansion into US stocks raises regulatory concerns

Polymarket is expanding its operations into US stocks, a move that has triggered significant regulatory concerns. This strategic push into the US stock market highlights ongoing regulatory challenges and may potentially reshape the landscape of prediction markets. Furthermore, these developments are expected to impact industry compliance norms as authorities monitor the integration of prediction markets with traditional financial assets, raising alarm bells regarding the legal framework governing such speculative activities in the United States.